Comment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence".
AOBiome LLC, One Broadway, 14th floor, Cambridge, MA, 02142, USA, dwhitlock@aobiome.com.
David R
DR
Whitlock
D000818:Animals; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D020521:Stroke / Q000150:complications* / Q000188:drug therapy*
D007074:Immunoglobulin G; D018696:Neuroprotective Agents; D018124:Receptors, Tumor Necrosis Factor